• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA VIDAS® LYME IGM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA VIDAS® LYME IGM Back to Search Results
Catalog Number 416436
Device Problem False Negative Result (1225)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
A customer from the united states notified biomérieux of false negative results associated with the vidas® lyme igm involving a patient sample.The customer indicated running the patient sample and getting negative result; however, the sample was sent to a reference lab where the western blot was positive for multiple bands.The customer reported the specimen they tested and the specimen the reference lab tested were obtained from the patient at the same time but were in different tubes.Serum was used for both tests.The customer indicated neither specimen is available for submission to biomérieux.A biomérieux investigation will be initiated.
 
Manufacturer Narrative
A customer from the united states had notified biomérieux of false negative results associated with the vidas® lyme igm involving a patient sample.An internal biomérieux investigation was performed.The patient sample was not submitted for evaluation.The analysis of the batch history records for vidas lyme igm ii lot 1005662400 /180708 0 showed no anomaly during the manufacturing and control processes.The analysis of control charts of eight (8) internal samples, one (1) negative, two (2) equivocal, five (5) positive, on eight (8) vidas lyme igm ii batches (including the lot mentioned by the customer) showed that all the results were within specifications.Vidas lyme igm ii lot 1005662400 /180708 0 is in the trend of the other batches.The complaint laboratory tested five internal samples, four (4) positive and one (1) negative, on a retain kit of vidas lyme igm ii lot 1005662400 /180708 0.The results obtained were within the expected specifications and similar to those obtained during release.There is no drift of vidas lyme igm ii lot 1005662400 /180708 0 since its release.As it was not possible to get the sample, no further investigation could be performed.Vidas lyme igm ii lot 1005662400 /180708 0 performed within the expected specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS® LYME IGM
Type of Device
VIDAS® LYME IGM
Manufacturer (Section D)
BIOMERIEUX SA
chemin de l orme
marcy l etoile, rhone 69280
FR 
MDR Report Key7076035
MDR Text Key94737638
Report Number3002769706-2017-00391
Device Sequence Number1
Product Code LSR
UDI-Device Identifier03573026447151
UDI-Public03573026447151
Combination Product (y/n)N
PMA/PMN Number
K122979
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 03/02/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/01/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/08/2018
Device Catalogue Number416436
Device Lot Number1005662400
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received02/06/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-